Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 60.86 Million USD | 0.08% |
| 2022 | 60.81 Million USD | -10.1% |
| 2021 | 67.65 Million USD | 16.56% |
| 2020 | 58.04 Million USD | -9.76% |
| 2019 | 64.32 Million USD | 1.81% |
| 2018 | 63.18 Million USD | 32.74% |
| 2017 | 47.59 Million USD | -1.69% |
| 2016 | 48.41 Million USD | -0.63% |
| 2015 | 48.72 Million USD | -1.26% |
| 2014 | 49.34 Million USD | 3.46% |
| 2013 | 47.69 Million USD | -9.01% |
| 2012 | 52.41 Million USD | 4.29% |
| 2011 | 50.26 Million USD | -2.93% |
| 2010 | 51.77 Million USD | 24.22% |
| 2009 | 41.68 Million USD | -1.12% |
| 2008 | 42.15 Million USD | 4.75% |
| 2007 | 40.24 Million USD | 5.67% |
| 2006 | 38.08 Million USD | 14.46% |
| 2005 | 33.27 Million USD | -27.78% |
| 2004 | 46.07 Million USD | 6.14% |
| 2003 | 43.41 Million USD | 52.01% |
| 2002 | 28.55 Million USD | 41.17% |
| 2001 | 20.22 Million USD | 30.72% |
| 2000 | 15.47 Million USD | 15.0% |
| 1999 | 13.45 Million USD | 97.8% |
| 1998 | 6.8 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 13.43 Million USD | -10.03% |
| 2024 Q2 | 11.88 Million USD | -11.55% |
| 2023 Q3 | 14.72 Million USD | -11.67% |
| 2023 FY | 60.86 Million USD | 0.08% |
| 2023 Q1 | 18.34 Million USD | 15.87% |
| 2023 Q4 | 14.93 Million USD | 1.43% |
| 2023 Q2 | 16.67 Million USD | -9.12% |
| 2022 Q4 | 15.83 Million USD | 30.08% |
| 2022 FY | 60.81 Million USD | -10.1% |
| 2022 Q3 | 12.17 Million USD | -26.84% |
| 2022 Q2 | 16.63 Million USD | 2.84% |
| 2022 Q1 | 16.17 Million USD | -17.3% |
| 2021 Q4 | 19.56 Million USD | 19.94% |
| 2021 Q1 | 15.43 Million USD | -12.86% |
| 2021 Q3 | 16.3 Million USD | -0.28% |
| 2021 Q2 | 16.35 Million USD | 5.97% |
| 2021 FY | 67.65 Million USD | 16.56% |
| 2020 Q3 | 13.49 Million USD | -2.61% |
| 2020 Q4 | 17.7 Million USD | 31.22% |
| 2020 FY | 58.04 Million USD | -9.76% |
| 2020 Q1 | 12.98 Million USD | -79.82% |
| 2020 Q2 | 13.85 Million USD | 6.73% |
| 2019 FY | 64.32 Million USD | 1.81% |
| 2019 Q3 | 14.97 Million USD | -6.12% |
| 2019 Q4 | 64.32 Million USD | 329.41% |
| 2019 Q2 | 15.95 Million USD | -1.23% |
| 2019 Q1 | 16.15 Million USD | -13.8% |
| 2018 FY | 63.18 Million USD | 32.74% |
| 2018 Q1 | 13.26 Million USD | 0.74% |
| 2018 Q3 | 15.81 Million USD | 3.01% |
| 2018 Q4 | 18.74 Million USD | 18.48% |
| 2018 Q2 | 15.35 Million USD | 15.72% |
| 2017 Q1 | 11.49 Million USD | -5.01% |
| 2017 FY | 47.59 Million USD | -1.69% |
| 2017 Q4 | 13.17 Million USD | 13.17% |
| 2017 Q3 | 11.63 Million USD | 3.12% |
| 2017 Q2 | 11.28 Million USD | -1.84% |
| 2016 Q3 | 11.69 Million USD | 0.13% |
| 2016 Q4 | 12.1 Million USD | 3.55% |
| 2016 Q1 | 12.94 Million USD | 0.16% |
| 2016 FY | 48.41 Million USD | -0.63% |
| 2016 Q2 | 11.67 Million USD | -9.81% |
| 2015 Q1 | 11.47 Million USD | -17.2% |
| 2015 Q3 | 11.72 Million USD | -6.9% |
| 2015 Q4 | 12.92 Million USD | 10.22% |
| 2015 FY | 48.72 Million USD | -1.26% |
| 2015 Q2 | 12.59 Million USD | 9.73% |
| 2014 Q1 | 11.76 Million USD | -2.24% |
| 2014 Q2 | 12.27 Million USD | 4.4% |
| 2014 FY | 49.34 Million USD | 3.46% |
| 2014 Q4 | 13.86 Million USD | 21.16% |
| 2014 Q3 | 11.44 Million USD | -6.81% |
| 2013 FY | 47.69 Million USD | -9.01% |
| 2013 Q4 | 12.03 Million USD | 6.43% |
| 2013 Q3 | 11.3 Million USD | -6.54% |
| 2013 Q2 | 12.09 Million USD | -1.39% |
| 2013 Q1 | 12.26 Million USD | -8.52% |
| 2012 Q3 | 11.99 Million USD | -11.91% |
| 2012 Q4 | 13.4 Million USD | 11.8% |
| 2012 Q1 | 13.4 Million USD | 1.31% |
| 2012 FY | 52.41 Million USD | 4.29% |
| 2012 Q2 | 13.61 Million USD | 1.6% |
| 2011 Q3 | 11.87 Million USD | -7.09% |
| 2011 Q2 | 12.78 Million USD | 3.36% |
| 2011 Q1 | 12.36 Million USD | -13.97% |
| 2011 FY | 50.26 Million USD | -2.93% |
| 2011 Q4 | 13.22 Million USD | 11.36% |
| 2010 Q2 | 12.05 Million USD | -5.73% |
| 2010 Q4 | 14.37 Million USD | 14.41% |
| 2010 FY | 51.77 Million USD | 24.22% |
| 2010 Q3 | 12.56 Million USD | 4.29% |
| 2010 Q1 | 12.78 Million USD | -2.44% |
| 2009 Q2 | 8.94 Million USD | -4.97% |
| 2009 Q1 | 9.41 Million USD | -19.07% |
| 2009 FY | 41.68 Million USD | -1.12% |
| 2009 Q4 | 13.1 Million USD | 28.09% |
| 2009 Q3 | 10.22 Million USD | 14.39% |
| 2008 Q1 | 10.33 Million USD | -10.67% |
| 2008 Q4 | 11.62 Million USD | 23.26% |
| 2008 FY | 42.15 Million USD | 4.75% |
| 2008 Q3 | 9.43 Million USD | -12.35% |
| 2008 Q2 | 10.76 Million USD | 4.18% |
| 2007 Q2 | 9.98 Million USD | 5.98% |
| 2007 Q1 | 9.42 Million USD | -11.14% |
| 2007 Q3 | 9.27 Million USD | -7.09% |
| 2007 FY | 40.24 Million USD | 5.67% |
| 2007 Q4 | 11.56 Million USD | 24.68% |
| 2006 Q4 | 10.6 Million USD | 13.23% |
| 2006 Q2 | 9.24 Million USD | 4.08% |
| 2006 Q1 | 8.88 Million USD | -2.61% |
| 2006 FY | 38.08 Million USD | 14.46% |
| 2006 Q3 | 9.36 Million USD | 1.31% |
| 2005 Q1 | 11.04 Million USD | -13.79% |
| 2005 Q2 | 6.86 Million USD | -37.85% |
| 2005 Q3 | 8.5 Million USD | 23.89% |
| 2005 Q4 | 9.11 Million USD | 7.21% |
| 2005 FY | 33.27 Million USD | -27.78% |
| 2004 Q3 | 11.4 Million USD | 0.92% |
| 2004 Q4 | 12.81 Million USD | 12.38% |
| 2004 Q2 | 11.29 Million USD | 6.36% |
| 2004 Q1 | 10.62 Million USD | -9.35% |
| 2004 FY | 46.07 Million USD | 6.14% |
| 2003 FY | 43.41 Million USD | 52.01% |
| 2003 Q2 | 11.41 Million USD | 16.06% |
| 2003 Q3 | 10.43 Million USD | -8.59% |
| 2003 Q4 | 11.71 Million USD | 12.26% |
| 2003 Q1 | 9.83 Million USD | 8.65% |
| 2002 Q2 | 7.07 Million USD | 13.79% |
| 2002 Q3 | 6.21 Million USD | -12.12% |
| 2002 Q1 | 6.21 Million USD | 8.85% |
| 2002 FY | 28.55 Million USD | 41.17% |
| 2002 Q4 | 9.05 Million USD | 45.69% |
| 2001 Q2 | 4.84 Million USD | 13.42% |
| 2001 Q3 | 5.42 Million USD | 12.04% |
| 2001 FY | 20.22 Million USD | 30.72% |
| 2001 Q1 | 4.26 Million USD | -49.81% |
| 2001 Q4 | 5.7 Million USD | 5.25% |
| 2000 FY | 15.47 Million USD | 15.0% |
| 2000 Q1 | 7.35 Million USD | 0.0% |
| 2000 Q4 | 8.5 Million USD | 15.63% |
| 2000 Q3 | 7.35 Million USD | 0.0% |
| 2000 Q2 | 7.35 Million USD | 0.0% |
| 1999 FY | 13.45 Million USD | 97.8% |
| 1998 FY | 6.8 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -8.101% |
| AngioDynamics, Inc. | 154.69 Million USD | 60.655% |
| AtriCure, Inc. | 300.37 Million USD | 79.736% |
| Avinger, Inc. | 2 Million USD | -2938.742% |
| Azenta, Inc. | 263.14 Million USD | 76.869% |
| BioLife Solutions, Inc. | 46.75 Million USD | -30.189% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 97.419% |
| Daxor Corporation | 1.1 Million USD | -5416.023% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -570.404% |
| Femasys Inc. | 691.9 Thousand USD | -8696.923% |
| GlucoTrack, Inc. | -13 Thousand USD | 468300.0% |
| Hologic, Inc. | 2.22 Billion USD | 97.268% |
| ICU Medical, Inc. | 739.87 Million USD | 91.773% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 98.713% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -264.286% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 52.092% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 51106.88% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 51106.88% |
| Masimo Corporation | 1 Billion USD | 93.935% |
| Microbot Medical Inc. | -106 Thousand USD | 57520.755% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -83.913% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 89.575% |
| Nephros, Inc. | 8.4 Million USD | -624.164% |
| NovoCure Limited | 381.05 Million USD | 84.027% |
| NEXGEL, Inc. | 619 Thousand USD | -9732.956% |
| NEXGEL, Inc. | 619 Thousand USD | -9732.956% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 11007.885% |
| OraSure Technologies, Inc. | 179.42 Million USD | 66.076% |
| Pro-Dex, Inc. | 14.55 Million USD | -318.294% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 5142.751% |
| Predictive Oncology Inc. | 1.14 Million USD | -5214.429% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -949.816% |
| QuidelOrtho Corporation | 1.49 Billion USD | 95.927% |
| Repligen Corporation | 315.22 Million USD | 80.691% |
| Sanara MedTech Inc. | 57.13 Million USD | -6.526% |
| STAAR Surgical Company | 252.65 Million USD | 75.909% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 6929.3% |
| Utah Medical Products, Inc. | 30.03 Million USD | -102.63% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 97.082% |
| Jin Medical International Ltd. | 6.78 Million USD | -797.089% |